Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1658 | 6876 | 45.3 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
642 | 3 | POLYCYSTIC KIDNEY DISEASE//AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE//HEDGEHOG | 12305 |
1658 | 2 | HEDGEHOG//GLI//CILIOPATHY | 6876 |
613 | 1 | HEDGEHOG//GLI//SMOOTHENED | 3247 |
1635 | 1 | JOUBERT SYNDROME//CILIOPATHY//BARDET BIEDL SYNDROME | 2561 |
15893 | 1 | ELLIS VAN CREVELD SYNDROME//JEUNE SYNDROME//ORAL FACIAL DIGITAL SYNDROME | 685 |
30188 | 1 | TUBBY//TULP1//ORF PHAGE DISPLAY | 173 |
32237 | 1 | ALSTROM SYNDROME//ALMS1//ALMS1 GENE | 142 |
37024 | 1 | RAB23//CARPENTER SYNDROME//ACROCEPHALOPOLYSYNDACTYLY TYPE II | 68 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEDGEHOG | authKW | 985813 | 8% | 42% | 535 |
2 | GLI | authKW | 564292 | 3% | 71% | 179 |
3 | CILIOPATHY | authKW | 532835 | 3% | 68% | 176 |
4 | SMOOTHENED | authKW | 516443 | 2% | 73% | 160 |
5 | HEDGEHOG SIGNALING | authKW | 515556 | 3% | 62% | 187 |
6 | SONIC HEDGEHOG | authKW | 466858 | 5% | 31% | 344 |
7 | JOUBERT SYNDROME | authKW | 450235 | 2% | 80% | 127 |
8 | PRIMARY CILIA | authKW | 448707 | 2% | 62% | 164 |
9 | BARDET BIEDL SYNDROME | authKW | 431072 | 2% | 75% | 130 |
10 | CYCLOPAMINE | authKW | 400544 | 2% | 65% | 138 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Developmental Biology | 19373 | 11% | 1% | 753 |
2 | Cell Biology | 16292 | 26% | 0% | 1783 |
3 | Genetics & Heredity | 12792 | 19% | 0% | 1297 |
4 | Oncology | 3258 | 13% | 0% | 902 |
5 | Biochemistry & Molecular Biology | 2632 | 20% | 0% | 1378 |
6 | Pediatrics | 1183 | 6% | 0% | 379 |
7 | Urology & Nephrology | 733 | 4% | 0% | 259 |
8 | Ophthalmology | 402 | 3% | 0% | 187 |
9 | Medicine, Research & Experimental | 375 | 4% | 0% | 273 |
10 | Pathology | 291 | 3% | 0% | 176 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HUMAN DIS MODELING | 63196 | 1% | 30% | 47 |
2 | SECT OPHTHALMOL NEUROSCI | 38052 | 0% | 30% | 29 |
3 | MOL MED UNIT | 20601 | 1% | 6% | 76 |
4 | TRYPANOSOME CELL BIOL UNIT | 18247 | 0% | 34% | 12 |
5 | CELL BIOL DEV DIS | 18120 | 0% | 58% | 7 |
6 | DEV BIOL STEM CELL BIOL REGENERAT MED | 17756 | 0% | 100% | 4 |
7 | GENET MED EA3949 | 17756 | 0% | 100% | 4 |
8 | GENET DEV EVOLUT | 17752 | 0% | 67% | 6 |
9 | NEUROBIOL ALFRED FESSARD IFR2118 | 17752 | 0% | 67% | 6 |
10 | REFERENCE AFFECT RA GENET OPHTALMOL CARGO | 17748 | 0% | 50% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEVELOPMENT | 13049 | 3% | 2% | 195 |
2 | AMERICAN JOURNAL OF MEDICAL GENETICS | 9030 | 2% | 2% | 135 |
3 | VITAMINS AND HORMONES | 8018 | 0% | 9% | 21 |
4 | DEVELOPMENTAL CELL | 6318 | 1% | 2% | 61 |
5 | DEVELOPMENTAL BIOLOGY | 5173 | 2% | 1% | 129 |
6 | JOURNAL OF MEDICAL GENETICS | 5020 | 1% | 1% | 82 |
7 | HUMAN MOLECULAR GENETICS | 4119 | 1% | 1% | 97 |
8 | METHODS IN CELL BIOLOGY | 3587 | 1% | 2% | 45 |
9 | CURRENT BIOLOGY | 3556 | 1% | 1% | 86 |
10 | AMERICAN JOURNAL OF MEDICAL GENETICS PART A | 3440 | 1% | 1% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEDGEHOG | 985813 | 8% | 42% | 535 | Search HEDGEHOG | Search HEDGEHOG |
2 | GLI | 564292 | 3% | 71% | 179 | Search GLI | Search GLI |
3 | CILIOPATHY | 532835 | 3% | 68% | 176 | Search CILIOPATHY | Search CILIOPATHY |
4 | SMOOTHENED | 516443 | 2% | 73% | 160 | Search SMOOTHENED | Search SMOOTHENED |
5 | HEDGEHOG SIGNALING | 515556 | 3% | 62% | 187 | Search HEDGEHOG+SIGNALING | Search HEDGEHOG+SIGNALING |
6 | SONIC HEDGEHOG | 466858 | 5% | 31% | 344 | Search SONIC+HEDGEHOG | Search SONIC+HEDGEHOG |
7 | JOUBERT SYNDROME | 450235 | 2% | 80% | 127 | Search JOUBERT+SYNDROME | Search JOUBERT+SYNDROME |
8 | PRIMARY CILIA | 448707 | 2% | 62% | 164 | Search PRIMARY+CILIA | Search PRIMARY+CILIA |
9 | BARDET BIEDL SYNDROME | 431072 | 2% | 75% | 130 | Search BARDET+BIEDL+SYNDROME | Search BARDET+BIEDL+SYNDROME |
10 | CYCLOPAMINE | 400544 | 2% | 65% | 138 | Search CYCLOPAMINE | Search CYCLOPAMINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRISCOE, J , THEROND, PP , (2013) THE MECHANISMS OF HEDGEHOG SIGNALLING AND ITS ROLES IN DEVELOPMENT AND DISEASE.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 14. ISSUE 7. P. 416-429 | 160 | 77% | 320 |
2 | TEGLUND, S , TOFTGARD, R , (2010) HEDGEHOG BEYOND MEDULLOBLASTOMA AND BASAL CELL CARCINOMA.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1805. ISSUE 2. P. 181 -208 | 280 | 67% | 198 |
3 | ROBBINS, DJ , FEI, DL , RIOBO, NA , (2012) THE HEDGEHOG SIGNAL TRANSDUCTION NETWORK.SCIENCE SIGNALING. VOL. 5. ISSUE 246. P. - | 196 | 87% | 98 |
4 | PANDOLFI, S , STECCA, B , (2015) COOPERATIVE INTEGRATION BETWEEN HEDGEHOG-GLI SIGNALLING AND OTHER ONCOGENIC PATHWAYS: IMPLICATIONS FOR CANCER THERAPY.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 17. ISSUE . P. - | 232 | 80% | 8 |
5 | YANG, L , XIE, G , FAN, Q , XIE, J , (2010) ACTIVATION OF THE HEDGEHOG-SIGNALING PATHWAY IN HUMAN CANCER AND THE CLINICAL IMPLICATIONS.ONCOGENE. VOL. 29. ISSUE 4. P. 469 -481 | 169 | 86% | 125 |
6 | WILSON, CW , CHUANG, PT , (2010) MECHANISM AND EVOLUTION OF CYTOSOLIC HEDGEHOG SIGNAL TRANSDUCTION.DEVELOPMENT. VOL. 137. ISSUE 13. P. 2079 -2094 | 178 | 88% | 77 |
7 | VARJOSALO, M , TAIPALE, J , (2008) HEDGEHOG: FUNCTIONS AND MECHANISMS.GENES & DEVELOPMENT. VOL. 22. ISSUE 18. P. 2454-2472 | 165 | 64% | 480 |
8 | GOETZ, SC , ANDERSON, KV , (2010) THE PRIMARY CILIUM: A SIGNALLING CENTRE DURING VERTEBRATE DEVELOPMENT.NATURE REVIEWS GENETICS. VOL. 11. ISSUE 5. P. 331 -344 | 114 | 73% | 612 |
9 | ISHIKAWA, H , MARSHALL, WF , (2011) CILIOGENESIS: BUILDING THE CELL'S ANTENNA.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 12. ISSUE 4. P. 222 -234 | 119 | 83% | 290 |
10 | MADHIVANAN, K , AGUILAR, RC , (2014) CILIOPATHIES: THE TRAFFICKING CONNECTION.TRAFFIC. VOL. 15. ISSUE 10. P. 1031 -1056 | 174 | 82% | 15 |
Classes with closest relation at Level 2 |